Kumar, 2019 - Google Patents
Lyophilization: An important formulation techniqueKumar, 2019
View PDF- Document ID
- 1253010960409116461
- Author
- Kumar P
- Publication year
- Publication venue
- Int. J. Res. Granthaalayah
External Links
Snippet
Lyophilization, is an important development for medicament formulation because of its ability to safely dry heat-sensitive vaccines, antibiotics, and protein-based formulations. The lyophilization process results in long shelf lives powder formulation which can be …
- 238000004108 freeze drying 0 title abstract description 38
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Walters et al. | Next generation drying technologies for pharmaceutical applications | |
Kumar | Lyophilization: An important formulation technique | |
Shukla | Freeze drying process: A review | |
Fonseca et al. | Freeze-drying of lactic acid bacteria | |
Gaidhani et al. | Lyophilization/freeze drying–a review | |
Butreddy et al. | Lyophilization of small-molecule injectables: an industry perspective on formulation development, process optimization, scale-up challenges, and drug product quality attributes | |
Franks | Freeze-drying of bioproducts: putting principles into practice | |
Patel et al. | Emerging freeze-drying process development and scale-up issues | |
US7153472B1 (en) | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers | |
Jadhav et al. | Review on lyophilization technique | |
AU2005249530A2 (en) | Preservation by vaporization | |
CN103041383A (en) | Heatproof freeze-drying protective agent of live vaccine, live vaccine freeze-drying powder and preparation method and preparation method of live vaccine freeze-drying powder | |
Adams | Freeze-drying of biological materials | |
Mehanna et al. | Recent advances in freeze-drying: variables, cycle optimization, and innovative techniques | |
Das et al. | Freeze-drying technique and its wide application in biomedical and pharmaceutical sciences | |
Adams | Lyophilization of vaccines: current trends | |
Gangurde et al. | Freeze drying: a review | |
EP3057611A1 (en) | Thermostable respiratory synctial virus (rsv) vaccine compositions | |
Varshney et al. | History of lyophilization | |
Kumar et al. | Fundamentals and applications of lyophilization | |
Silambarasan et al. | A review on freeze-drying: A stability enhancement technique | |
Khandagale et al. | Lyophilization Technique: A Review | |
WO2001037804A2 (en) | Preservation and formulation of bioactive materials | |
Yang et al. | Collapse temperature of solutions important for lyopreservation of living cells at ambient temperature | |
Lovalenti et al. | Foam drying |